Cytokeratin 19 antibody (C-Term)
-
- Target See all Cytokeratin 19 (KRT19) Antibodies
- Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))
-
Binding Specificity
- AA 386-399, C-Term
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Monoclonal
-
Conjugate
- This Cytokeratin 19 antibody is un-conjugated
-
Application
- Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Purpose
- Anti-Cytokeratin 19
- Specificity
- Cytokeratin 19
- Immunogen
- Peptide derived from C-terminal region of human cytokeratin 19. Antibody recognizes the epitope between Gly386 - Val399.
- Clone
- E16-L
- Isotype
- IgG
- Top Product
- Discover our top product KRT19 Primary Antibody
-
-
- Application Notes
- 1:100 - 200
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- 20 mM Tris-HCI, pH 8.0, Stabilizer: 20 mg/mL BSA, Preservative: 0.05 % sodium azide
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- 4 °C
- Storage Comment
- +2 °C to +8 °C
-
- Target
- Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))
- Alternative Name
- Cytokeratin 19 (KRT19 Products)
- Background
- Cytokeratin 19 expression is associated with a wide variety of epithelium and epithelial malignancies including adenocarcinomas of the colon, stomach, pancreas, biliary tract, liver and breast.
- UniProt
- P08727
-